Michael S. Harper

520 total citations
14 papers, 298 citations indexed

About

Michael S. Harper is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Michael S. Harper has authored 14 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 12 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Michael S. Harper's work include HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (6 papers). Michael S. Harper is often cited by papers focused on HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (6 papers). Michael S. Harper collaborates with scholars based in United States, Germany and Sweden. Michael S. Harper's co-authors include Mario L. Santiago, Kejun Guo, Bradley S. Barrett, Cara C. Wilson, Stephanie M. Dillon, Martin D. McCarter, Eric Lee, Ulf Dittmer, Kathrin Gibbert and Sam X. Li and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michael S. Harper

14 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S. Harper United States	11	211	183	67	64	50	14	298
Franco Pissani United States	11	295 1.4×	305 1.7×	86 1.3×	80 1.3×	86 1.7×	13	417
Alexandre Vasilescu France	10	137 0.6×	159 0.9×	46 0.7×	75 1.2×	69 1.4×	11	277
R. Glenn Overman United States	8	154 0.7×	186 1.0×	49 0.7×	61 1.0×	55 1.1×	11	242
S. Abigail Smith United States	7	137 0.6×	209 1.1×	28 0.4×	82 1.3×	80 1.6×	14	241
Yanina Ghiglione Argentina	11	183 0.9×	184 1.0×	33 0.5×	84 1.3×	70 1.4×	26	287
John Bui United States	5	158 0.7×	184 1.0×	81 1.2×	72 1.1×	107 2.1×	9	295
Rodney Trout United States	10	189 0.9×	112 0.6×	61 0.9×	105 1.6×	88 1.8×	12	320
Anna Haas Switzerland	7	188 0.9×	156 0.9×	70 1.0×	75 1.2×	89 1.8×	7	325
Takayuki Chikata Japan	15	349 1.7×	348 1.9×	117 1.7×	51 0.8×	108 2.2×	37	451
Suefen Kwa United States	9	315 1.5×	284 1.6×	55 0.8×	112 1.8×	82 1.6×	10	436

Countries citing papers authored by Michael S. Harper

Since Specialization

Citations

This map shows the geographic impact of Michael S. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Harper more than expected).

Fields of papers citing papers by Michael S. Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Harper. The network helps show where Michael S. Harper may publish in the future.

Co-authorship network of co-authors of Michael S. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Harper. A scholar is included among the top collaborators of Michael S. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Harper. Michael S. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Andersen‐Nissen, Erica, Andrew Fioré-Gartland, Lamar Ballweber-Fleming, et al.. (2021). Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk. PLoS Pathogens. 17(3). e1009363–e1009363. 20 indexed citations

Schroeder, Kristin, Pamela Strauch, Michael S. Harper, et al.. (2017). Breaching peripheral tolerance promotes the production of HIV-1–neutralizing antibodies. The Journal of Experimental Medicine. 214(8). 2283–2302. 25 indexed citations

Barrett, Bradley S., Michael S. Harper, Kejun Guo, et al.. (2017). Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction. Retrovirology. 14(1). 25–25. 6 indexed citations

Yoder, Alyson, Kejun Guo, Stephanie M. Dillon, et al.. (2017). The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria. PLoS Pathogens. 13(2). e1006226–e1006226. 26 indexed citations

Dillon, Stephanie M., Eric Lee, Kejun Guo, et al.. (2016). Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection. Retrovirology. 13(1). 5–5. 54 indexed citations

Harper, Michael S., Kejun Guo, Kathrin Gibbert, et al.. (2015). Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms. PLoS Pathogens. 11(11). e1005254–e1005254. 67 indexed citations

Guo, Kejun, Kimberly Schmitt, Yaqiong Wang, et al.. (2015). Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques. Immunogenetics. 67(7). 355–370. 5 indexed citations

Gibbert, Kathrin, Sandra Francois, Anna M. Sigmund, et al.. (2014). Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. Retrovirology. 11(1). 126–126. 16 indexed citations

Barrett, Bradley S., Kejun Guo, Michael S. Harper, et al.. (2014). Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. Virology. 468-470. 601–608. 14 indexed citations

10.

Li, Sam X., Bradley S. Barrett, Michael S. Harper, et al.. (2013). Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection. Virology. 443(1). 134–142. 10 indexed citations

11.

Barrett, Bradley S., et al.. (2013). Fv1 Restriction and Retrovirus Vaccine Immunity in Apobec3-Deficient 129P2 Mice. PLoS ONE. 8(3). e60500–e60500. 6 indexed citations

12.

Harper, Michael S., Bradley S. Barrett, Diana S. Smith, et al.. (2013). IFN-α Treatment Inhibits Acute Friend Retrovirus Replication Primarily through the Antiviral Effector Molecule Apobec3. The Journal of Immunology. 190(4). 1583–1590. 19 indexed citations

13.

Harper, Michael S., et al.. (2012). Humoral immunity in the Friend retrovirus infection model. Immunologic Research. 55(1-3). 249–260. 16 indexed citations

14.

Biberfeld, Peter, et al.. (1988). Lymphadenopathy in HIV (HTLV-III/LAV) infected subjects: the role of virus and follicular dendritic cells.. PubMed. 12(1-6). 217–24. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact